Adjuvant Pembrolizumab after Upfront Multimodal Therapy for Stage IVB Anaplastic Thyroid Cancer
Thyroid® · 01.07.2025 · 35 (7) · 763-770
DOI: 10.1089/thy.2025.0194 ↗Kurz gefasst
Klinische Studie (Phase II) in der Zeitschrift Thyroid®, erschienen am 01.07.2025. Verfasst von Maria E Cabanillas und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer, Houston, Texas, USA. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Humanized, Thyroid Carcinoma, Anaplastic, Thyroid Neoplasms, Antineoplastic Agents, Immunological. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 18 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer, Houston, Texas, USA.
- Department of Radiation Oncology, The University of Texas MD Anderson Cancer, Houston, Texas, USA.
- Department of Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer, Houston, Texas, USA.
- Department of Neuroradiology, The University of Texas MD Anderson Cancer, Houston, Texas, USA.
- Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer, Houston, Texas, USA.
- Department of Pathology, The University of Texas MD Anderson Cancer, Houston, Texas, USA.
ORCID-Profile: Maria E Cabanillas, Anastasios Maniakas, Sarah Hamidi, Jennifer R Wang, Vicente R Marczyk, Mark Zafereo
Zitieren
APA
Cabanillas, M. E., Busaidy, N. L., Gunn, G. B., Iyer, P. C., Ferrarotto, R., Gule-Monroe, M., Maniakas, A., Williams, M. D., Liu, S., Fellman, B., Spiotto, M., Hamidi, S., Akhave, N., Lee, A., Wang, J. R., de Sousa, L., Marczyk, V. R., Zafereo, M., & Dadu, R. (2025). Adjuvant Pembrolizumab after Upfront Multimodal Therapy for Stage IVB Anaplastic Thyroid Cancer. Thyroid®, 35(7), 763-770. https://doi.org/10.1089/thy.2025.0194
Vancouver
Cabanillas ME, Busaidy NL, Gunn GB, Iyer PC, Ferrarotto R, Gule-Monroe M, et al. Adjuvant Pembrolizumab after Upfront Multimodal Therapy for Stage IVB Anaplastic Thyroid Cancer. Thyroid®. 2025;35(7):763-770. doi:10.1089/thy.2025.0194
BibTeX
@article{Cabanillas2025,
author = {Cabanillas, Maria E and Busaidy, Naifa L and Gunn, G Brandon and Iyer, Priyanka C and Ferrarotto, Renata and Gule-Monroe, Maria and Maniakas, Anastasios and Williams, Michelle D and Liu, Suyu and Fellman, Bryan and Spiotto, Michael and Hamidi, Sarah and Akhave, Neal and Lee, Anna and Wang, Jennifer R and de Sousa, Luana and Marczyk, Vicente R and Zafereo, Mark and Dadu, Ramona},
title = {Adjuvant Pembrolizumab after Upfront Multimodal Therapy for Stage IVB Anaplastic Thyroid Cancer},
journal = {Thyroid®},
year = {2025},
volume = {35},
number = {7},
pages = {763--770},
doi = {10.1089/thy.2025.0194}
}
EUVIMED